Insights into Mycobacterium leprae Proteomics and Biomarkers-An Overview

Sakshi Gautam1,2, Devesh Sharma1, Anjana Goel2

  • 1Department of Biochemistry, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra 282004, India.

Proteomes
|February 12, 2021
PubMed

Insights

Identifying leprosy biomarkers through proteomics is crucial for early diagnosis and reducing disease transmission. This research reviews proteomic studies to find new diagnostic markers for leprosy, especially for paucibacillary cases.

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Leprosy, a curable infectious disease, requires early diagnosis to minimize transmission and prevalence.
  • Current diagnostic biomarkers for leprosy, particularly for paucibacillary forms, are not sufficiently defined.
  • Identifying novel biomarkers is a key research priority for effective leprosy control.

Purpose of the Study:

  • To review the current knowledge on leprosy and its causative agent, *Mycobacterium leprae*, using proteomic approaches.
  • To highlight the potential of proteomics in identifying and characterizing leprosy-specific protein biomarkers.
  • To explore the role of proteomics in advancing the diagnosis and understanding the pathogenesis of leprosy.

Main Methods:

  • Proteomic analysis of *Mycobacterium leprae* and host-pathogen interactions.
  • Identification and quantification of proteins associated with leprosy.
  • Bioinformatic analysis of proteomic data for biomarker discovery.

Main Results:

  • Proteomics enables the identification and characterization of potential diagnostic markers.
  • Proteomic studies contribute to a deeper understanding of leprosy pathogenesis.
  • The review consolidates findings from various proteomic investigations in leprosy research.

Conclusions:

  • Proteomics offers a powerful strategy for discovering novel biomarkers for early leprosy diagnosis.
  • Further proteomic research is essential for developing accurate diagnostic tools and therapeutic targets.
  • Understanding the proteome of *Mycobacterium leprae* and its interaction with the host is key to combating leprosy.